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Hantavirus infection is associated with two frequently fatal diseases in humans:
Hemorrhagic fever with renal syndrome (HFRS) and hantavirus pulmonary syndrome
(HPS). The pathogenesis of hantavirus infection is complex and not fully understood;
however, it is believed to involve virus-induced hyperinflammatory immune responses.
Thrombospondin-1 (THBS1) is a large homotrimeric protein that plays a putative
role in regulating blood homeostasis. Hyperresponsiveness to inflammatory stimuli
has also been associated with defects in the THBS1 gene. Our data suggest that
hantavirus infection of human umbilical cord vein endothelial cells (HUVEC) suppress
the accumulation of THBS1 in the extracellular matrix. Additionally, this suppression is
dependent on virus replication, implying a direct mechanism of action. Our data also
imply that the pathogenic Andes and Hantaan strains inhibit THBS1 expression while the
non-pathogenic Prospect Hill strain showed little inhibition. These observations suggest
that a dysregulation of THBS1may contribute to the pathogenesis of hantavirus infection.
Keywords: coagulation, HPS, HFRS, THBS1, TSP1, Prospect Hill, Hantaan, Andes
INTRODUCTION
Hantaviruses are negative strand RNA viruses belonging to the family Bunyaviridae (Schmaljohn
and Nichol, 2001; Schmaljohn, 2007). They are the etiological agent associated with two frequently
fatal human illnesses: Hemorrhagic fever with renal syndrome (HFRS) and hantavirus pulmonary
syndrome (HPS; Jenison et al., 1995; Enria et al., 2001; Linderholm and Elgh, 2001; Peters and Khan,
2002). Postmortem analyses of HFRS and HPS cases typically reveal high viral loads in endothelial
cells, suggesting that the vascular endothelium is a principal site of infection (Zaki et al., 1995).
In vitro studies have confirmed that human vascular endothelial cells are susceptible to hantavirus
infection; however, infection does not produce a visible cytopathic effect (Pensiero et al., 1992;
Khaiboullina et al., 2004).
HFRS and HPS are characterized by high fever and myalgia; however, kidney failure and
bleeding are typical of HRFS while HPS manifests with pneumonia and cardiovascular dysfunction
(Kanerva et al., 1998; Enria et al., 2001; Linderholm and Elgh, 2001). Despite different clinical
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presentations, decreased platelet counts, and changes in blood
chemistry are commonly observed during the early phase of
both syndromes (Kanerva et al., 1998; Peters et al., 1999).
Disturbed hemostasis is a hallmark of HFRS (Linderholm and
Elgh, 2001; Sundberg et al., 2011) as is progressive disseminated
intravascular coagulation (DIC) syndrome (Connolly-Andersen
et al., 2015); however, severe shock and renal failure tend to
associate with more severe illness (Lee et al., 1989; Rasche et al.,
2004; Sundberg et al., 2011). HPS commonly manifests with
pneumonia and severe cardiovascular dysfunction as a result
of progressive leakage of fluid from the blood into the lungs,
resulting in pulmonary edema, hypoxia, and circulatory collapse
(Enria et al., 2001). Although DIC is not the most prevalent
pathology during HPS, laboratory, and histological examinations
have revealed the presence of all symptoms of DIC (Zaki et al.,
1995). DIC is an acquired disorder in which the proteins that
control blood clotting become constitutively activated, resulting
in consumption of platelets and conversion of fibrinogen to fibrin
(Slofstra et al., 2003). With blood platelets and clotting factors
exhausted, internal, and external bleeding typically ensues (Peters
et al., 1999). In the normal steady state, endothelial cells control
blood homeostasis by continuously expressing several proteins
(Cirino et al., 2000; Dugina et al., 2002), many of which interact
with thrombospondin-1 (THBS1); a large trimeric glycoprotein
secreted by several cell types including endothelial cells, and
activated platelets (McPherson et al., 1981; Mast et al., 2000;
Resovi et al., 2014; Prakash et al., 2015).
Once secreted, THBS1 suppresses proliferation and migration
of endothelial cells, as well as signals their apoptosis (Khan
et al., 1996; Lawler and Detmar, 2004). Additionally, THBS1
can induce endothelial cell actin reorganization and focal
adhesion disassembly (Greenwood et al., 1998; Goicoechea
et al., 2000). Several proteases involved in angiogenesis and
endothelial integrity, such as urokinase, plasminogen, matrix
metalloproteinase, thrombin, cathepsin, and elastase are also
influenced by THSB1 (Hogg et al., 1993; Albo et al., 1997;
Bein and Simons, 2000; Liu et al., 2009; Yang et al., 2012;
Zhao et al., 2015). Furthermore, THBS1 can directly affect
the activity of plasmin and urokinase plasminogen activator,
which are important for degradation of fibrin (Silverstein et al.,
1986; Hogg et al., 1992; Rabhi-Sabile et al., 1998). Finally,
THBS1 controls von Willebrand (vW) factor multimer sizes by
reduction of disulfide bonds, which link the vW factor subunits
together (Xie et al., 2001). Secretion of THBS1 by endothelial
cells can be modulated by proinflammatory cytokines such as
TNFα and IL-1, two cytokines that are commonly observed in
association with hantavirus infection (McPherson et al., 1981;
Lawler and Detmar, 2004; Lopez-Dee et al., 2011). Indeed,
several proteins modulated by THBS1 have been implicated
in hantavirus pathology. For instance, Bondu and coworkers
observed elevated levels of thrombin in severe HPS cases (Saumet
et al., 2002; Bondu et al., 2015) and Sadeghi et al. observed TGFB1
to be elevated during the late phase of Puumala hantavirus
infection (Sadeghi et al., 2011; Chu et al., 2013). Also, Strandin
and colleagues reported that tissue plasminogen activator was
strongly upregulated in severe cases of Puumala hantivirus
infection (Strandin et al., 2016). Additionally, Davidovich et al.
reported a three-fold increase in serum vW in HRFS patients
during their oliguric phase (Davidovich et al., 1993). Although
the molecular mechanisms involved in hantavirus pathology are
not well-understood it is reasonable that THBS1 may play a
role in the pathophysiology of hantavirus infection through the
interactions with the abovementioned proteins.
Recently, decreased levels of serumTHBS1 have been reported
in association with HFRS (Liu et al., 2008; Laine et al., 2014).
Liu et al. suggested that insufficient production or increased
consumption of THBS1 contribute to the impaired integrity
of small capillaries in subjects with HFRS (Liu et al., 2008).
In the present study, we demonstrate that in vitro hantavirus
infection of endothelial cells suppresses transcription of THBS1
and its subsequent accumulation in the extracellular matrix. This
suppression is dependent on viral replication, but is independent
of IL-6 and CCL5 expression by infected cells. Additionally, these
observations were strain-specific with the pathogenic Andes
(ANDV) and Hantaan (HTNV) strains suppressing THBS1
expression while non-pathogenic Prospect Hill (PHV) strain
showed little inhibition.
METHODS
Human umbilical cord vein endothelial cells (HUVEC) and Vero
clone E6 (Vero E6) were obtained from Lonza, Inc. (Portsmouth,
NH) and American Type Culture Collection (ATCC, Manassas,
VA), respectively. HUVEC were grown in MCDB 131 medium,
supplemented with human vascular endothelial cell growth
factor, hydrocortisone, 2% fetal bovine serum (FBS), human
fibroblast growth factor (0.5mL; 1µg/mL), ascorbic acid, heparin
(0.5mL; 1µg/mL), and gentamicin. Cells were used at passages
2–4. Vero E6 cells were grown in DMEM medium containing
20% FBS and gentamicin.
All work with infectious virus was conducted in a BSL-3
facility, in compliance with a Memorandum of Understanding
with the University of Nevada, Reno, as well as according to NIH,
CDC, and OSHA standards. All virus stocks were propagated
on Vero E6 cells. Andes virus strain 23 (ANDV) and Hantaan
virus strain 76–118 (HTNV) were a generous gift from Dr.
Thomas Ksiazek (CDC, Atlanta, GA), and Prospect Hill virus
(PHV) was a generous gift from Dr. Connie Schmaljohn (Fort
Detrick, MD). In all experiments, cells were infected at a virus
to cell ratio of 3 (MOI of 3) except where indicated. In some
experiments, the virus was inactivated with 2 × 106 rads of
gamma radiation. Infections were conducted by incubating each
respective virus on HUVEC for 1 h at 37◦C, 5% CO2. The cell
monolayers were then washed with HBBS, and new medium was
added and the incubation continued for the times indicated. For
some experiments, new culture medium was supplemented with
10 ng/mL TNFα, 10 ng/mL TGFβ, 50 ng/ml IL-6, or 12 ng/mL
CCL5 (R&D Systems). Mock-infected cells and/or untreated
cells were used as controls. All experiments were done in
duplicate.
Immunofluorescence
Hantavirus-infected and mock-infected HUVEC monolayers
were fixed with methanol/acetone (3:1), washed three times with
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PBS (pH 7.4), and incubated with glycine buffer (10mM glycine
in PBS pH 7.4) for 30min at room temp. Slides were again
washed three times with PBS and permeabilized with Triton-X
100 solution (0.1% in PBS pH 7.4) for 30min at room temp.
Slides were next washed three times with PBS and incubated
for 30min at room temp with an appropriate combination of
antibodies (summarized in Table 1). Slides were washed again
three times in PBS, and incubated with the respective antibody
combinations for 30min at room temp in the dark. Images were
captured using a Nikon C1 fluorescent microscope with Easy C1
software.
Western Blot
Hantavirus-infected and mock-infected HUVEC were lysed
in 200µL of 0.1% sodium dodecyl sulfate (SDS) solution
and standardized using the Better BradfordTM Assay Kit
(Pierce, Div. of Thermo Fisher, Waltham, MA). Proteins were
electroblotted for 15min, at 4mA/cm2 onto PVDF membranes
(Bio-Rad, Hercules, CA) and blocked for 1 h at room temp
with blocking buffer (5% non-fat dry milk in PBS, pH 7.4
and 0.5% Tween 20). Membranes were then washed three
times in washing buffer (PBS pH 7.4 and 0.5% Tween 20)
and incubated with the respective antibodies in blocking
buffer for 12 h at 4◦C. Antigen–antibody complexes were
identified with goat anti-rabbit-HRP or goat anti-mouse-HRP
conjugated antibodies (1:1000 in blocking buffer) and developed
using insoluble HRP substrate (Vector Labs, Burlingame, CA)
according to the manufacturer’s instructions. Western blots were
quantitatively measured using Scion Image software version
beta 4.0.2.
Real Time PCR
Hantavirus-infected HUVEC and mock-infected cells were
collected at selected time points and total RNA was extracted
using Trizol reagent (Life Technologies, Carlsbad, CA),
according to the manufacturer’s instructions. To conduct
first strand cDNA synthesis, 3µL RNA (1µg total), 1µL
random primer mix (50µM), and 8.5µL RNase-free water were
combined, denatured at 70◦C for 10min, and chilled at 4◦C to
anneal the primers. cDNA was then synthesized by adding 1µL
of each dNTP (10mM; GIBCO, Division of Life Technologies),
1x RT buffer (Promega, Madison, WI), 200 U of MMLV reverse
transcriptase (Promega), and 20 U of rRNasin RNAse inhibitor
TABLE 1 | Antibodies.
Antibody Concentration Supplier
Mouse anti-THBS1mAb 1:400 Sigma
Mouse anti-PUU* mAb 1:100 Dr. Thomas Ksiazek (CDC)
Mouse anti-p-c-Jun mAb 1:100 Santa-Cruz
Rabbit anti-NF-kB 1:100 Santa-Cruz
Rabbit anti-N Protein 1:500 In house
Goat anti-mouse-Alexa 488 1:800 Molecular probes
Donkey anti-rabbit-Alexa 555 1:800 Molecular probes
*Hantavirus (Puumala) nucleocapsid protein.
(Promega) in a 20µL total reaction volume. After incubation for
10min at 25◦C, the reaction proceeded for 1 h at 42◦C and was
terminated by heating at 95◦C for 5min. cDNA was stored at
−20◦C until analyzed.
TaqMan analyses were performed using TaqMan minor
groove binding probes on an ABI Prism 7000 Sequence Detection
System. Each PCR reaction (25µL) consisted of 1µL of cDNA,
1õ Platinum qPCR Supermix-UDG (Life Technologies), 200 nM
of each primer, and 100 nM of probe. The cDNA of each
respective sample was diluted 1:1000 with nuclease free water
before TaqMan analyses. The 18S ribosomal gene was used as an
endogenous control for all analyses. Standard curves for relative
quantification of viral S segment RNA, cellular genes, and 18S
RNA were created using serial dilutions of cDNA from infected
and uninfected control samples depending on specifics of the
experimental design. All TaqMan reactions were performed in
triplicate. In TaqMan experiments, TaqMan values of cellular
gene mRNA were normalized against TaqMan values for the
18S gene of a corresponding sample. For some experiments,
normalized values were expressed as relative values to the
same gene expressed in the corresponding control group. The
sequences of primers and probe for THBS1 are summarized in
Table 2.
Statistical Analysis
Data are presented as mean ± SE. Statistical analyses were
performed using Student’s t-test for comparisons between
individual experimental groups (infected and non-infected).
Significance was established at a value of p < 0.01.
RESULTS
Effect of ANDV, HTNV, and PHV Infection
and Cytokine Treatment on THBS1
Accumulation in the Extracellular Matrix of
HUVEC
A central dogma of hantavirus pathogenesis is that virus
replication leads to endothelial cell dysregulation (Connolly-
Andersen et al., 2014). THBS1 is an extracellular matrix protein
TABLE 2 | Sequence and position of primers and probes used for TaqMan.
Gene Forward primer Reverse primer TaqMan probe
ANDV* tcacgccaggacgatttagg
(414–433)
ggctttgacctgtgctggaa
(472–453)
caattgcttgtggcctt
(435–451)
PHV* ggctgacaaagtaaaggcatt
tc (738–760)
cgtggctcagcctttaggaa
(797–778)
tgaccagaaatgtcc
(761–776)
HTV* gcagcagttagcctccttggt
(787–807)
tgccgctgccgtaagtagt
(845–827)
tcctgcaacaaacagg
(810–825)
THBS1 gaggcggcctcccctat
(1115–1131)
tcaacagtccattcctcgttatttc
(1180–1156)
tatcacaacggagttcag
tac (1134–1154)
RANTES cccgcagaggaagcacaa
(858–875)
gcgaagatttcccgtaaactttc
(919–897)
actacgcgggctgc
(861–875)
IL-6 ctgcgcagctttaaggagttc
(513–533)
ccatgctacatttgccgaaga
(574–554)
cagtccagcctgaggg
(537–552)
*Nucleocapsid “S” segment.
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secreted by endothelial cells and has putative roles in cell
adhesion, platelet aggregation, and the regulation of fibrinolysis
(Silverstein et al., 1984; Roberts et al., 2010). With this in mind,
we sought to determine if hantavirus infection and replication
affects THBS1 accumulation in cultured HUVEC. Additionally,
we investigated if pathogenic ANDV and HTNV and non-
pathogenic PHV differ in their abilities to influence THBS1
accumulation.
HUVEC monolayers infected with ANDV, HTNV, and PHV
were fixed and probed by immunohistochemistry (IHC) for
THBS1 accumulation in the extracellular matrix (Figure 1). In
mock-infected cells, THBS1 was equally distributed throughout
the extracellular matrix (Figure 1A). In contrast, accumulation
of THBS1 was greatly reduced in ANDV and HTNV infected
HUVEC (Figures 1B,C, respectively). In cells infected with
PHV, accumulation of THBS1 was observed throughout the
extracellular matrix similar to that observed in uninfected control
cells (Figure 1D).
The interactions between THBS1 and transforming growth
factor beta (TGFβ) are complex. TGFβ can regulate the
expression of extracellular matrix proteins, including THBS1
(Negoescu et al., 1995; Nakagawa et al., 2005). Conversely,
discrete sequences of THBS1 have been shown to activate
TGFβ (Schultz-Cherry et al., 1995). Therefore, in order to
investigate the effect of TGFβ on the accumulation of THBS1 in
hantavirus-infected cells we duplicated the above experiment but
supplemented the HUVEC culture media with TGFβ. Treatment
of mock-infected cells with TGFβ did not significantly affect
FIGURE 1 | THBS1 accumulation in the extracellular matrix of HUVEC monolayers infected with pathogenic (ANDV and HTNV) and non-pathogenic
(PHV) hantavirus in the presence and absence of TGFβ or TNFα. Monolayers were infected at MOI 3, with the indicated strains, treated with 10 ng/mL of TGFβ
or TNFα, and fixed at 72 h PI. Monolayers were stained with rabbit anti-hantavirus N protein polyclonal antibody followed by donkey anti-rabbit-Alexa 555 secondary
(red) and mouse anti-THBS1mAb followed by a goat anti-mouse-Alexa 488 secondary (green). (A) Mock infected, no treatment; (B) ANDV infected, no treatment; (C)
HTNV infected, no treatment; (D) PHV infected, no treatment; (E) Mock infected, TGFb treated; (F) ANDV infected, TGFb treated; (G) HTNV infected, TGFb treated;
(H) PHV infected, TGFb treated; (I) Mock infected, TNFa treated; (J) ANDV infected, TNFa treated; (K) HTNV infected, TNFa treated; (L) PHV infected, TNFa treated.
Frontiers in Microbiology | www.frontiersin.org 4 July 2016 | Volume 7 | Article 1077
Khaiboullina et al. Hantavirus Suppression of Thrombospondin-1
THBS1 accumulation in the extracellular matrix (Figure 1E);
however, when ANDV-infected TGFβ treated and non-treated
cells were compared, a significant increase in the accumulation
of THBS1 was observed in the TGFβ-treated cells (Figure 1F).
Interestingly, when compared to untreated cells, TGFβ did not
substantially affect THBS1 accumulation in the extracellular
matrix of cells infected with HTNV and PHV (Figures 1G,H,
respectively).
Previous reports suggest that secretion of THBS1 by
endothelial cells may be modulated by proinflammatory
cytokines such as tumor necrosis factor alpha (TNFα; Morandi
et al., 1994). To investigate this possibility in the context
of hantavirus infection, 10 ng/mL of TNFα was added to
the culture media of hantavirus infected, and mock-infected
HUVEC. Addition of TNFα reduced THBS1 accumulation in
the extracellular matrix of mock-infected HUVEC (Figure 1I).
THBS1 no longer appeared equally distributed throughout the
monolayer as seen in the mock-infected control without TNFα
treatment. THBS1 accumulation in the matrix of ANDV and
HTNV infected HUVEC remained low after treatment with
TNFα (Figures 1J,K, respectively). Although PHV infection
did not affect accumulation of THBS1 in the extracellular
matrix of untreated cells, TNFα treatment did inhibited THBS1
accumulation in PHV infected cells similar to that of uninfected
controls (Figure 1L).
Transcriptional Activation of THBS1 in
Hantavirus Infected HUVEC
The effects of hantavirus infection and TNFα treatment on
THBS1 transcription were analyzed using TaqMan (Figure 2).
Untreated and TNFα-treated (10 ng/mL) HUVEC were infected
with ANDV, HTNV, PHV, or mock-infected and total RNA was
collected at 12, 24, and 72 h post infection (PI). Pathogenic
ANDV and HTNV showed significantly reduced transcriptional
activity of THBS1 in HUVEC 12 h PI when compared to mock-
infected cells (p < 0.01; Figures 2.2, 2.3). Transcription of
THBS1 RNA in ANDV and HTNV infected cells returned to
the levels of mock-infected cells at 72 h PI (Figures 2.2, 2.3).
In HUVEC infected with non-pathogenic PHV, THBS1 RNA
levels did not differ significantly from that of mock-infected
HUVEC at all time points PI (Figure 2.4). TNFα treatment
significantly suppressed THBS1 RNA levels in mock-infected
HUVEC at 12, 24, and 72 h PI compared to untreated cells
(p < 0.01; Figure 2.5). THBS1 RNA levels were reduced in
TNFα-treated HUVEC infected with pathogenic ANDV and
HTNV similar to that of uninfected TNFα-treated controls at all
time points (p < 0.01; Figures 2.6, 2.7). Interestingly, THBS1
RNA levels in PHV-infected HUVEC treated with TNFα did not
differ significantly from that of PHV-infected cells without TNFα
treatment at 12 h PI (Figures 2.4, 2.8). However, THBS1 RNA
levels were significantly lower in PHV-infected HUVEC treated
with TNFα as compared to that in PHV-infected cells without
TNFα treatment at 24 and 72 h PI (p < 0.01; Figures 2.4, 2.8).
Effect of Hantavirus Replication on THBS1
Accumulation in the Extracellular Matrix of
HUVEC
To assess if an active infection is required for the accumulation
of THBS1 in the extracellular matrix, HUVEC were inoculated
with ANDV and HTNV, as well as the same viruses inactivated
by gamma radiation. Total RNA was then collected at selected
time points after inoculation (1, 24, 48, and 72 h PI) for
evaluation using TaqMan. ANDV and HTNV S segment RNA
was measured to confirm hantavirus replication (data not
shown). Transcriptional activity of THBS1 in HUVEC inoculated
with inactivated ANDV or HTNV did not differ significantly
from that of mock-infected HUVEC at all selected time points
(1, 24, 48, and 72 h PI; Figure 3A). However, the levels of
FIGURE 2 | Transcriptional activation of THBS1 in hantavirus infected HUVEC. Cells were infected with pathogenic (ANDV and HTNV) and non-pathogenic
(PHV) hantaviruses at MOI 3. TNFα was used at 10 ng/mL where indicated. Total RNA was collected at 12, 24, and 72 h PI and used to determine transcription of
THBS1 mRNA by TaqMan analysis. Values of THBS1 mRNA were normalized to the 18S mRNA in the corresponding sample. Relative units of THBS1 mRNA were
obtained by dividing normalized THBS1 values of infected cells by those of uninfected controls. Each experiment was performed three times and each TaqMan
reaction was performed in duplicate. (1) Uninfected, (2) ANDV infected, (3) HTNV infected, (4) PHV infected, (5) TNFα treated, (6) TNFα treated and ANDV infected,
(7) TNFα treated and HTNV infected, (8) TNFα treated and PHV infected.
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FIGURE 3 | Effect of hantavirus replication on THBS1 transcriptional
activity and protein expression in HUVEC. Cells were inoculated with
gamma radiation inactivated or infectious ANDV and HTNV at MOI of 1. Total
RNA was collected and used to evaluate THBS1 transcription (A). Values of
THBS1 were normalized to the corresponding values of 18S RNA. Relative
units were calculated by dividing normalized values in infected group by
normalized values in mock-infected control group. To determine the effect of
hantavirus replication on THBS1 protein accumulation in HUVEC (B), Total
proteins collected from HUVEC inoculated with gamma radiation inactivated
and infectious ANDV and HTNV (MOI 1; 72 h PI) were separated by
SDS-PAGE and transferred onto the PVDF membrane. Membranes were
probed with anti-THBS1mAb followed by anti-mouse HRP-conjugated
secondary antibody. 1. Mock infected, 2. Inactivated ANDV, 3. Inactivated
HTNV, 4. Infectious ANDV, and 5. Infectious HTNV.
FIGURE 4 | Effect of hantavirus replication on NF-kB expression and
c-Jun activation. Total proteins collected from HUVEC inoculated with
gamma radiation inactivated and infectious ANDV and HTV (MOI of 1; 72 h PI)
were separated in SDS-PAGE and transferred onto the PVDF membrane.
Membranes were probed with anti-NF-kB (A) or anti-phospho-c-Jun (B) mAbs
followed by anti-mouse-HRP conjugated secondary antibody.
THBS1 RNA were significantly lower in HUVEC inoculated with
competent ANDV or HTNV at each selected time point PI when
compared to cells inoculated with inactivated ANDV or HTNV
(p < 0.01; Figure 3A). The effects of competent and gamma-
irradiated ANDV and HTNV on the expression of THBS1 in
HUVEC were also analyzed using Western blot (Figure 3B).
THBS1 expression in HUVEC inoculated with gamma-irradiated
ANDV or HTNV did not differ from that of mock-infected
HUVEC (Figure 3B). In contrast, cells infected with competent
ANDV or HTNV showed clear reduction in THSB1 expression
(Figure 3B).
Effect of Hantavirus Replication on c-Jun
Activation and NF-kB Expression
Gamma-irradiation hinders virus replication, but preserves viron
integrity, thus allowing viral proteins to interact with cellular
proteins in the absence of virus replication. Additionally, it has
been shown that the expression of THBS1 can be inhibited
by activation of the c-Jun member of the AP-1 family of
transcription factors (Bohmann et al., 1987; Curran and Franza,
1988), as well as NF-kB activation (Cinatl et al., 2000). With this
in mind, we sought to determine if viral replication was required
to activate these transcription factors. We observed similar
levels of NF-kB expression and c-Jun activation in HUVEC
inoculated with inactivated or competent ANDV and HTNV
(Figures 4A,B, respectively at 72 h PI). These observations
suggest NF-kB expression and c-Jun activation are independent
of virus replication and, therefore, are unlikely to represent the
mechanism of THSB1 inhibition by hantaviruses.
Activation of CCL5 and IL-6 Expression in
HUVEC Infected with ANDV, HTNV, and
PHV
Hantaviruses may affect the expression of THBS1 in endothelial
cells by indirect mechanisms such as by promoting cytokine
and chemokine production. At least two cytokines, TNFα and
interleukin-1 (IL-1), have been shown to suppress THBS1
expression by endothelial cells (Morandi et al., 1994). However,
we as well as others have shown that hantavirus infection does not
activate TNFα or IL-1 expression in endothelial cells (Sundstrom
et al., 2001; Geimonen et al., 2002; Khaiboullina et al., 2004).
Nevertheless, we have previously shown that hantaviruses
promote the expression of CCL5 in HUVEC (Khaiboullina et al.,
2004). During the course of these previous studies, we did not
observe any changes in IL-6 gene expression in hantavirus-
infected cells at early time points (3 and 12 h PI; Khaiboullina
et al., 2004). We did however observe that the transcriptional
regulator nuclear factor for interleukin-6 (CCAAT/Enhancer
Binding Protein), which activates IL-6 gene expression (Akira
et al., 1990; Kinoshita et al., 1992), was upregulated in infected
cells (Geimonen et al., 2002; Khaiboullina et al., 2004) suggesting
that IL-6 expressionmight be activated at a later time point. Based
upon these data, we hypothesized that hantavirus-induced CCL5
and IL-6 expression may lead to a change in the accumulation
of THBS1 in HUVEC. We therefore infected HUVEC with
ANDV, HTNV, and PHV and collected total RNA at selected time
points (12, 24, and 72 h PI) for TaqMan analysis and collected
cell culture media supernatants for cytokine analysis by ELISA.
Mock-infected cells were used as controls.
When compared to mock-infected cells, HUVEC infected
with ANDV, HTNV, and PHV were observed to upregulate levels
of CCL5 RNA at 12, 24, and 72 h PI (Figure 5A). Additionally,
transcription of IL-6 was significantly increased in HTNV and
PHV-infected HUVEC at 24 h PI and increased for all viruses
at 72 h PI, when compared to mock-infected cells (p < 0.01;
Figure 5B). Also, the levels of CCL5 and IL-6 were significantly
increased in culture supernatant of HUVEC infected with ANDV,
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HTNV, and PHV at 72 h PI when compared to mock-infected
cells (p < 0.01; Figures 5C,D, respectively).
During the course of these experiments, we observed that
the maximum concentration of CCL5 and IL-6 found in
supernatants of hantavirus-infected HUVEC cultures was 12 and
50 ng/mL, respectively. Therefore, we used these concentrations
to treat uninfected HUVEC in order to assess the effect of CCL5
or IL-6 on THBS1 accumulation in the extracellular matrix. No
changes in THBS1 accumulation were observed upon treatment
of HUVEC with CCL5 or IL-6 when compared to untreated
controls, as determined by Western blot analysis (Figure 5E),
suggesting that the effect was not strictly the result of these
inflammatory cytokines.
DISCUSSION
Although it has been suggested that the high viral loads observed
in the endothelial cells of those with HFRS and HPS is related
to disease pathogenesis (Yi et al., 2014; Bellomo et al., 2015), the
mechanisms of pathogenesis remains unknown. Hantaviruses are
not cytopathic in vitro (Pensiero et al., 1992; Sundstrom et al.,
2001; Khaiboullina et al., 2004), and no pathological evidence
of virus-induced cell death has been reported in tissues from
fatal hantavirus cases (Zhang et al., 1987; Zaki et al., 1995). The
absence of virus-induced cytopathicity in vitro is in stark contrast
with the severe vascular disorders observed during HPS and
HFRS (Sargianou et al., 2012; Manigold and Vial, 2014). For this
reason, it has been suggested that hantavirus pathology more
likely involves a dysregulation of the infected endothelial cell’s
ability to support their primary function as a blood-tissue barrier
(Connolly-Andersen et al., 2014).
In this report, we have demonstrated the in vitro suppression
of THBS1 transcription in endothelial cells through hantavirus
infection. We additionally show that hantavirus infection
reduces THBS1 protein accumulation in the extracellular
matrix of endothelial cells. Importantly, the inhibitory effects
of hantavirus infection were strain specific, whereby, the
pathogenic hantaviruses ANDV and HTNV were more effective
in suppressing the extracellular matrix accumulation of THBS1.
On the other hand, the effects of the non-pathogenic PHV
were less pronounced. Additionally, suppression of THBS1 was
dependent on virus replication and did not require the presence
of CCL5 or IL-6. Our data suggests that hantavirus infection
directly influences the expression and accumulation of THBS1,
an endothelial cell protein with putative roles in cell adhesion,
platelet aggregation, and the regulation of fibrinolysis (Silverstein
et al., 1984; Roberts et al., 2010). These data support a mechanism
of disease pathogenesis characterized by decreased expression
FIGURE 5 | Transcriptional activity and secretion of CCL5 and IL-6 in hantavirus-infected cells. Total RNA and cell culture supernatants were collected from
hantavirus infected cells at 12, 24, and 72 h PI. Transcription of CCL5 (A) and IL-6 (B) was analyzed using TaqMan. Levels of CCL5 (C) and IL-6 (D) in cell culture
media were determined using ELISA. Effect of IL-6 and CCL5 on THBS1 expression in HUVEC by Western blot (E). Total proteins were collected from cells either
untreated, treated with 50 ng/mL IL-6 or 12 ng/mL of CCL5 for 72 h. Proteins were separated by SDS-PAGE, transferred onto PVDF membrane and probed with
anti-THBS1mAb antibodies followed by anti-mouse-HRP conjugated secondary antibody.
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of THBS1 in infected endothelial cells, which in turn leads
to a perturbation of normal vascular integrity, and possibly
hemostasis, which ultimately contribute to the severe vascular
disorders characteristic of pathogenic hantavirus pathology
(Adams, 1997; Sargianou et al., 2012; Manigold and Vial, 2014).
This pathology may include loss of renal function, capillary
leakage, and thrombocytopenia (Thakar et al., 2005; Garg et al.,
2011; Sargianou et al., 2012; Vaheri et al., 2013; Latus et al.,
2015).
Among the many functions of THBS1, three are of particular
interest in relation to hantavirus pathogenesis: first, THBS1
controls vW factor multimer sizes (Xie et al., 2001; Pimanda
et al., 2004). vW factor mediates adhesion of platelets at sites of
vascular injury; however, only the very large vW factor multimers
are effective in promoting platelet adhesion (Sadler, 1998; Xie
et al., 2001). THBS1 can reduce intersubunit disulfide bonds
of vW factor leading to formation of smaller multimers that
have significantly lower activity for platelet aggregation, thus
preventing thrombosis (Thakar et al., 2005) and protecting the
integrity of vascular endothelium (Xie et al., 2001).
Second, THBS1 suppresses plasminogen activator inhibitor,
which allows tissue plasminogen activator and urokinase
plasminogen activator to convert plasminogen into plasmin,
the principal enzyme responsible for fibrin degradation in the
process of fibrinolysis (Silverstein et al., 1986; Hogg et al., 1992;
Rabhi-Sabile et al., 1998). Accordingly, an absence of THBS1 and
a decrease in fibrinolysis, may lead to excessive coagulation and
consumption of clotting factors (Lee, 1987). However, THBS1
is also a slow tight-binding inhibitor of plasmin (Hogg et al.,
1992). Therefore, in one context THBS1 may increase platelet
aggregation, but in another context prevents blood clots from
developing and becoming problematic. In fact, THBS1 released
from activated platelets participates both in the formation as well
as the resolution of the fibrin clot (Adams, 1997). Accordingly,
THBS1 likely influences the balance between procoagulation and
anticoagulation proteins, in a context-dependent manner, thus
regulating blood flow.
Finally, Bauer et al. reported that circulating THBS1 blocks
endothelial-dependent decreases in blood pressure by limiting
the production of the diffusible vasodilator nitric oxide (NO;
Bauer et al., 2010). Consistent with this observation, and in the
context of this study, Liu et al., reported decreased circulating
levels of THBS1 in subjects with HFRS (Liu et al., 2008). These
data offer an alternative mechanism that is not directly related
to the coagulation cascade. By suppressing THBS1 expression
in endothelial cells, hantaviruses may affect normal blood flow
by decreasing thrombolysis, promoting platelet aggregation, and
increasing vascular permeability. However, it should be noted
that blood homeostasis is a dynamic process, involving many
proteins. THBS1 is known to interact with as many as 50
different proteins (Resovi et al., 2014), and therefore, the precise
mechanism of THBS1’s involvement may be indirect or through
undetermined interactions.
In a previous study to characterized ANDV infection
in its native host, Peromyscus maniculatus, Spengler et al.,
reported that the largely anti-inflammatory cytokine TGFβ
was markedly upregulated (Spengler et al., 2013). They
further speculate that this observation may explain why
ANDV infection in not associated with any clinical signs of
pathology in its native host. We observed a paucity of THBS1
accumulation in the extracellular matrix of ANDV-infected
HUVEC, however, when ANDV-infected cells were treated with
TGFβ, a significant increase in the accumulation of THBS1
was observed (Figure 1F). We also observed this effect to be
suppressed in the presence of the proinflammatory cytokine
TNFα. Indeed, it has been reported that TNFα antagonizes
the activities of TGFβ and is believed to play an essential
role in maintaining the stability of extracellular matrix proteins
(Verrecchia et al., 2000; Verrecchia and Mauviel, 2004).
As shown in Figure 2, treatment of HUVEC with TNFα also
suppressed THBS1 gene transcription in uninfected endothelial
cells. In fact, THBS1 distribution in the extracellular matrix of
TNFα-treated and uninfected endothelial cells appear similar
to that of untreated endothelial cells infected with pathogenic
hantaviruses (Figure 1). Several signal transduction pathways
are activated by TNFα that can affect THBS1 accumulation,
including c-Jun and NF-κB transcription activation factors
(Manna et al., 1998; Rahman, 2000). For instance, Kim and Hong
reported that decreased THBS1, in response to the inflammatory
stimuli phorbol 12-myristate 13-acetate, was regulated by c-Jun
(Kim andHong, 2000). Our data suggest that hantavirus infection
activates c-Jun; therefore, it is possible that TNFα may synergizes
hantavirus-triggered activation of transcription factors including
those involved in THBS1 accumulation. Although TNFα is not
directly produced by endothelial cells, an increase in serumTNFα
has been reported in the blood of hantavirus infected cases
(Krakauer et al., 1995).
While non-pathogenic PHV suppressed the accumulation of
THBS1 protein in endothelial cells, the effect was less pronounced
when compared to pathogenic strains. Similarly, PHV was
not a strong suppressor of THBS1 gene transcription when
compared to pathogenic hantaviruses. These data suggest that
the non-pathogenic hantavirus have less effect on the expression
of endothelial cell proteins involved in the control of blood
homeostasis than pathogenic hantaviruses. These observations
potentially identify a mechanism for the different pathologies of
different hantavirus strains.
Finally, our data suggest that hantavirus replication is required
for the suppression of THBS1 accumulation. Although CCL5
and IL-6 upregulation did not suppress THBS1 accumulation,
it’s possible that c-Jun may be involved. It has been shown
for several other viruses that viral proteins can modulate cell
protein transcription by interacting with transcription activation
factors. For example, the major early regulatory protein large
T-Ag, of John Cunningham virus (JC virus), can interact with
AP-1 transcription activation proteins (Kim et al., 2003). Also,
hepatitis C virus has been shown to activate c-Jun N-terminal
kinase and p38mitogen-activated protein (MAP) kinase (Erhardt
et al., 2002). Themechanisms of transcription factor activation by
hantaviruses remain to be determined; however, it is possible that
viral proteins and/or RNA-protein complexes may be involved as
suggested by the activation of c-Jun.
In summary, our data suggest that pathogenic Andes and
Hantaan virus infection of endothelial cells suppress the
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accumulation of THBS1 in the extracellular matrix while the
non-pathogenic Prospect Hill strain display little inhibition.
THBS1 interacts with numerous members of the coagulation
cascade, suggesting a mechanism of pathology. However, the
pathophysiology of hantavirus infection is complex and involves
not only the dysregulation of coagulation, hyperinflammatory
immune responses likely play an important role, that may be
independent of coagulation. Although the involvement of THBS1
suggests a potential disease mechanism, further studies will
be required to fully understand its involvement in the disease
process.
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